Literature DB >> 12525285

The Role of Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Sanjay Sethi1.   

Abstract

Our understanding of the pathogenesis and consequences of acute exacerbations of chronic obstructive pulmonary disease (COPD) has increased considerably in the past decade. Several new lines of evidence support bacterial causation of about half the exacerbations. Contrary to previous data, recent studies with improved methodology have demonstrated that exacerbations do contribute to the loss of lung function in COPD. Another interesting new observation is that colonization by bacterial pathogens may not be innocuous, and in fact may lead to airway inflammation and contribute to pathogenesis of COPD. Evidence that bacteria cause exacerbations, that exacerbations contribute to loss of lung function, and that chronic colonization by bacteria may be harmful, has emphasized the potential importance of appropriate antibiotics in the treatment of exacerbations. An unfortunate paucity of data does not allow evidence-based recommendations to be made for optimal choice of antibiotics for exacerbations of COPD. Emerging data that antibiotics differ in unconventional measures of efficacy such as time to next exacerbation, improvement in health-related quality of life, and bacteriologic eradication will help us make concrete recommendations in the future.

Entities:  

Year:  2003        PMID: 12525285     DOI: 10.1007/s11908-003-0059-x

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  31 in total

1.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; A Bhowmik; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

Review 2.  Role of infection in chronic bronchitis.

Authors:  I Tager; F E Speizer
Journal:  N Engl J Med       Date:  1975-03-13       Impact factor: 91.245

Review 3.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 4.  Infectious etiology of acute exacerbations of chronic bronchitis.

Authors:  S Sethi
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

5.  Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease.

Authors:  Faris Bakri; Aimee L Brauer; Sanjay Sethi; Timothy F Murphy
Journal:  J Infect Dis       Date:  2002-02-05       Impact factor: 5.226

6.  Role of infection in chronic bronchitis.

Authors:  D W Gump; C A Phillips; B R Forsyth; K McIntosh; K R Lamborn; W H Stouch
Journal:  Am Rev Respir Dis       Date:  1976-04

7.  Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis.

Authors:  K Yi; S Sethi; T F Murphy
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

8.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.

Authors:  E Monsó; J Ruiz; A Rosell; J Manterola; J Fiz; J Morera; V Ausina
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

9.  Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation.

Authors:  R Pela; F Marchesani; C Agostinelli; D Staccioli; L Cecarini; C Bassotti; C M Sanguinetti
Journal:  Monaldi Arch Chest Dis       Date:  1998-06

10.  New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Nancy Evans; Brydon J B Grant; Timothy F Murphy
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

View more
  3 in total

1.  Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis.

Authors:  Federico Pea; Federica Pavan; Emilio Lugatti; Flavio Dolcet; Giovanni Talmassons; Maria Consuelo Screm; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  The quality of life impact of acute exacerbations of chronic bronchitis (AECB): a literature review.

Authors:  Jordana K Schmier; Michael T Halpern; Mitchell K Higashi; Alan Bakst
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

3.  Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis.

Authors:  Sanjay Sethi; Antonio Anzueto; David J Farrell
Journal:  Ann Clin Microbiol Antimicrob       Date:  2005-03-08       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.